Selincro is a drug used in the treatment of alcoholism, along with psychological support to promote adherence to treatment and reduction of alcohol consumption. The active substance in this medicine is nalmefeno.
Selincro is a medicine produced by the Lundbeck laboratory, being found in tablet form.
Indications of Selincro
Selincro is indicated for the reduction of alcohol consumption in adult patients with alcohol dependence, without physical withdrawal symptoms and who do not require immediate detoxification.
How to use Selincro
The mode of use of Selincro consists of taking a maximum dose of 1 tablet per day.
Before starting treatment should be assessed the patient's clinical status, alcohol dependence and the level of alcohol consumption, by the physician. Selcinro can be taken with or without food.
Side effects of Selincro
The side effects of Selcinro may be decreased appetite, insomnia, disturbance, confusional state, restlessness, decreased libido, loss of libido) hallucination, hallucination, tactile hallucination, dissociation, dizziness, headache, drowsiness, tremor, disorders, paresthesia, hyposthesia, tachycardia, palpitations, nausea, vomiting, dry mouth, hyperhidrosis, muscle spasms, fatigue, asthenia. general malaise, unpleasant feeling or decreased weight.
Contraindications of Selincro
Selincro is contraindicated in patients older than or equal to 65 years, people with renal and hepatic problems, or who have hypersensitivity to any component of Selincro.
Selincro is not recommended during pregnancy. The safety and efficacy of Selincro in children and adolescents over 18 years of age have not been established.
Selincro is also contraindicated by patients taking opioid analgesics, current or recent opioid dependence, and acute opioid withdrawal symptoms, with suspected recent opioid use.
Useful links:
Remedy to quit drinking
